Adendra Therapeutics

Translating dendritic cell biology into new therapies for cancer and autoimmunity.

General Information
Company Name
Adendra Therapeutics
Founded Year
2021
Location (Offices)
London, United Kingdom +1
Founders / Decision Makers
Number of Employees
2
Industries
Biopharma, Biotechnology, Health Care
Funding Stage
Series A
Social Media

Adendra Therapeutics - Company Profile

Adendra Therapeutics is an emerging biotechnology company focusing on translating dendritic cell biology into new therapies for cancer and autoimmunity. The company, founded in 2021, is dedicated to discovering and developing new small molecule and biologic medicines for the treatment of a wide range of cancers and autoimmune diseases.

Headquartered in the United Kingdom, Adendra Therapeutics recently secured a significant £40.00M Series A investment on 07 December 2021, with the funding coming from Apple Tree Partners. This capital injection is poised to propel the company's innovative research and development efforts aimed at addressing the unmet medical needs in the biopharma, biotechnology, and healthcare sectors.

For more information about Adendra Therapeutics, please visit their website at www.adendratx.com.

Taxonomy: dendritic cell biology, cancer therapy, autoimmune diseases, small molecule medicines, biologic medicines, drug discovery, immunotherapy, biopharmaceuticals, oncology treatment

Funding Rounds & Investors of Adendra Therapeutics (1)

View All
Funding Stage Amount No. Investors Investors Date
Series A £40.00M 1 07 Dec 2021

Latest News of Adendra Therapeutics

View All

No recent news or press coverage available for Adendra Therapeutics.

Similar Companies to Adendra Therapeutics

View All